12
Treatment
Figure 4. Flowchart Showing Key Action Statements and
Process of Care
NO
Age ≥5 years with AR
Educate patients
about SLIT vs. SCIT
Educate patients
about benefits
of AIT
Offers pre- and co-
seasonal AIT
Continue
escalation or
maintenance
dosing
Limit AIT to clinically
relevant and
confirmed antigens
Polysensitized
patient
(multiple allergens)?
Start AIT
End
Do not
initiate AIT
KAS
1
KAS
2A
KAS 4
Local
reactions to AIT
allergens?
Decision to
use SLIT?
Change in
environmental
exposures or loss
of control of
symptoms?
Symptoms
inadequately controlled
by medical therapy or allergen
avoidance or both?
Pregnant,
uncontrolled asthma, or
unable to tolerate injectable
epinephrine?
YES
YES
YES
YES
NO
NO
NO
NO
NO
NO
NO
KAS 5
KAS 6
KAS 7
KAS 8
KAS
9
KAS
11
